Evaluation of the efficacy and safety of 5-aminolevulinic acid-mediated photodynamic therapy in women with high-risk HPV persistent infection after cervical conization
- 6 October 2022
- journal article
- research article
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 40, 103144
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Nanoparticle‐based photothermal and photodynamic immunotherapy for tumor treatmentInternational Journal of Cancer, 2018
- The precision prevention and therapy of HPV ‐related cervical cancer: new concepts and clinical implicationsCancer Medicine, 2018
- Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic reviewInternational Journal of Cancer, 2017
- Topical photodynamic therapy with 5-aminolevulinic acid for cervical high-risk HPV infectionPhotodiagnosis and Photodynamic Therapy, 2016
- Overview of high-risk HPV's 16 and 18 infected cervical cancer: Pathogenesis to preventionBiomedicine & Pharmacotherapy, 2015
- The immune system in menopause: Pros and cons of hormone therapyThe Journal of Steroid Biochemistry and Molecular Biology, 2014
- 5‐aminolevulinic acid‐based photodynamic therapy for the treatment of condylomata acuminata in Chinese patients: a meta‐analysisPhotodermatology, Photoimmunology & Photomedicine, 2013
- Persistent HPV infection after conization in patients with negative marginsGynecologic Oncology, 2006
- Human Papillomavirus and Cervical CancerClinical Microbiology Reviews, 2003
- The ThinPrep Pap TestActa Cytologica, 1997